NCT06080061View on ClinicalTrials.gov

Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer

PHASE1RecruitingINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

October 25, 2023

Primary Completion Date

November 30, 2026

Study Completion Date

December 31, 2026

Conditions

Lung Cancer

Interventions

RADIATION

Hypofractionated accelerated radiation therapy

Hypofractionated accelerated radiation therapy

Trial Locations (1)

94305

RECRUITING

Stanford University, Palo Alto

All Listed Sponsors

collaborator

LUNGevity Foundation

OTHER

lead

Stanford University

OTHER